GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Other Income (Expense)

Big Pharma Split (FRA:XN4) Other Income (Expense) : €0.00 Mil (TTM As of Jun. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Big Pharma Split Other Income (Expense)?

Big Pharma Split's other income expense for the Big Pharma Split's pretax income for the six months ended in Jun. 2024 was €0.00 Mil. Its other income expense for the trailing twelve months (TTM) ended in Jun. 2024 was €0.00 Mil.

Big Pharma Split Other Income (Expense) Historical Data

The historical data trend for Big Pharma Split's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Big Pharma Split Other Income (Expense) Chart

Big Pharma Split Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial - - - - -

Big Pharma Split Semi-Annual Data
Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Big Pharma Split Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Big Pharma Split  (FRA:XN4) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Big Pharma Split Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Big Pharma Split Corp (FRA:XN4) » Definitions » Other Income (Expense)
Comparable Companies
TSX:XTD TSXV:MIVO TSXV:CSOC.A NEOE:JPEG XCNQ:SOL TSXV:TORR TSXV:CLCO TSXV:AIVC TSXV:ELC XCNQ:TLP.UN BLK BX KKR OSTO:INVE A TSX:BAM TSX:BN APO LSE:III AMP XSWX:PGHN
Traded in Other Exchanges
PRM.PR.A.PFD:Canada PRM:Canada
Address
610 Chartwell Road, Suite 204, Oakville, ON, CAN, L6J 4A5
Website
https://www.harvestportfolios.com
Big Pharma Split Corp is a mutual fund corporation. Its investment objective is to provide shareholders with fixed cumulative preferential quarterly cash distributions, and regular monthly cash distributions. The company has a presence in the United States; Switzerland; France and United Kingdom.

Big Pharma Split Headlines

No Headlines